Detalhe da pesquisa
1.
Increased autocrine interleukin-6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia.
J Cell Physiol
; 234(8): 13994-14006, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623437
2.
Differential and tumor-specific expression of CD160 in B-cell malignancies.
Blood
; 118(8): 2174-83, 2011 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21715317
3.
CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.
Blood
; 115(15): 3079-88, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20164468
4.
Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay.
Front Oncol
; 10: 597730, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33344247
5.
STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
Oncotarget
; 7(22): 32031-45, 2016 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27074565
6.
CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 22(10): 2462-9, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712690
7.
Risk factors for cancer-associated venous thromboembolism in outpatient deep venous thrombosis clinics.
Br J Haematol
; 150(5): 640-1, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20560972
8.
Impact of venous thromboembolism on survival in patients with malignancy.
Br J Haematol
; 145(2): 258-60, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19222473
9.
More on thromboprophylaxis: quantifying risk for venous thromboembolism.
Thromb Haemost
; 101(4): 791-4, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19350133
10.
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression.
J Am Soc Nephrol
; 13(3): 630-638, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11856766